908 DEVICES INC (MASS)

908 Devices to Participate in Upcoming Investor Conferences

MASS Makes Bullish Cross Above Critical Moving Average

MASS Stock Earnings: 908 Devices Beats EPS, Beats Revenue for Q1 2024

MASS stock results show that 908 Devices beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

908 Devices Reports First Quarter 2024 Financial Results and Updates 2024 Revenue Outlook

908 Devices Acquires RedWave Technology, Expanding its Forensics Product Offering

908 Devices to Report First Quarter 2024 Financial Results on April 30, 2024

908 Devices Trace Chemical Identification Technology Adopted by European Agencies

908 Devices Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Revenue Outlook

908 Devices and Cellares Collaborate to Integrate In-line Monitoring of Bioprocess Parameters into the Cell Shuttle, Cellares’ Fully Integrated Cell Therapy Manufacturing Platform

908 Devices to Participate in Upcoming Investor Conferences

908 Devices to Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024

Commit To Buy 908 Devices At $5, Earn 14.4% Annualized Using Options

908 Devices CFO Joe Griffith discloses sale of 6K shares (NASDAQ:MASS)

CFO of 908 Devices sells 6,000 shares for $72,480 as MASS stock declines by 7.9%.

Notable Thursday Option Activity: MASS, UNH, QCOM

2 Cathie Wood Stocks That Could Soar in 2024, According to Wall Street

Wall Street is uber-bullish on these two Ark Invest holdings.

3 Russell 2000 Stocks That Are About to Get Absolutely Crushed

The Russell 2000 has only begun closing its wide gap with other indices, but investors should be weary of these three stocks to sell.

908 Devices Announces MX908 Integration Capabilities

908 Devices Reports Third Quarter 2023 Financial Results and Narrows 2023 Revenue Outlook

908 Devices and Terumo Blood and Cell Technologies Collaborate to Add On-line Analytics to Quantum Flex Cell Expansion System

908 Devices to Participate in Upcoming Investor Conferences

908 Devices Enters Oversold Territory (MASS)

Commit To Buy 908 Devices At $5, Earn 32.4% Annualized Using Options

908 Devices Awarded $10.4M Order from the United States Air Force for its Handheld MX908 Device

908 Devices to Report Third Quarter Financial Results on November 7, 2023

908 Devices Enters Initial Production Phase of US Department of Defense Aerosol and Vapor Chemical Agent Detector Program

908 Devices Launches MAVERICK for Real-Time In-Line Monitoring of Multiple Bioprocess Parameters

908 Devices to Participate in the Gilmartin Group Emerging Growth Company Showcase

3 Cathie Wood Stocks With Parabolic Growth Potential, According to Wall Street

These cutting-edge biotech stocks could deliver life-changing gains for early shareholders.

908 Devices Reports Second Quarter 2023 Financial Results and Updates 2023 Revenue Outlook